Cargando…
Engineering a new vaccine platform for heterologous antigen delivery in live-attenuated Mycobacterium tuberculosis
Live vaccines are attractive vehicles for antigen delivery as a strategy to immunize against heterologous pathogens. The live vaccine MTBVAC is based on rational attenuation of Mycobacterium tuberculosis with the objective of improving BCG protection against pulmonary tuberculosis. However, the deve...
Autores principales: | Broset, Esther, Calvet Seral, Juan, Arnal, Carmen, Uranga, Santiago, Kanno, Alex I., Leite, Luciana C.C., Martín, Carlos, Gonzalo-Asensio, Jesús |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355830/ https://www.ncbi.nlm.nih.gov/pubmed/34429847 http://dx.doi.org/10.1016/j.csbj.2021.07.035 |
Ejemplares similares
-
Evolutionary Landscape of the Mycobacterium tuberculosis Complex from the Viewpoint of PhoPR: Implications for Virulence Regulation and Application to Vaccine Development
por: Broset, Esther, et al.
Publicado: (2015) -
MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice
por: Broset, Esther, et al.
Publicado: (2019) -
BCG vaccination improves DTaP immune responses in mice and is associated with lower pertussis incidence in ecological epidemiological studies
por: Broset, Esther, et al.
Publicado: (2021) -
Targeted Chromosomal Barcoding Establishes Direct Genotype-Phenotype Associations for Antibiotic Resistance in Mycobacterium abscessus
por: Calvet-Seral, Juan, et al.
Publicado: (2023) -
Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis
por: Aguilo, Nacho, et al.
Publicado: (2017)